IRIS
PANTANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.948
NA - Nord America 1.410
EU - Europa 601
SA - Sud America 259
AF - Africa 25
OC - Oceania 13
AN - Antartide 1
Totale 8.257
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.438
US - Stati Uniti d'America 1.330
CN - Cina 726
HK - Hong Kong 518
BR - Brasile 189
IT - Italia 167
GB - Regno Unito 131
VN - Vietnam 124
DE - Germania 81
CA - Canada 45
IN - India 45
NL - Olanda 39
AR - Argentina 35
MX - Messico 25
FI - Finlandia 24
CZ - Repubblica Ceca 20
FR - Francia 20
JP - Giappone 20
ID - Indonesia 19
TR - Turchia 18
ES - Italia 14
RU - Federazione Russa 14
ZA - Sudafrica 14
PL - Polonia 13
UA - Ucraina 13
AU - Australia 12
SE - Svezia 12
AT - Austria 10
BD - Bangladesh 10
EC - Ecuador 10
EE - Estonia 9
KR - Corea 7
CL - Cile 5
CO - Colombia 5
LT - Lituania 5
PY - Paraguay 5
VE - Venezuela 5
RO - Romania 4
SA - Arabia Saudita 4
BE - Belgio 3
DK - Danimarca 3
GR - Grecia 3
PT - Portogallo 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MS - Montserrat 1
MW - Malawi 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
SI - Slovenia 1
TH - Thailandia 1
TO - Tonga 1
TW - Taiwan 1
YE - Yemen 1
Totale 8.257
Salva come PNG Salva come JPEG
Città #
Hong Kong 517
Singapore 459
Hefei 330
Ashburn 303
Dallas 227
Boardman 172
Beijing 157
London 116
Shanghai 113
Los Angeles 58
Ho Chi Minh City 45
Munich 40
Rome 40
San Francisco 40
Amsterdam 25
Santa Clara 25
Council Bluffs 24
Pune 24
Hanoi 23
New York 23
São Paulo 23
Toronto 21
Brooklyn 20
Brno 19
Mexico City 18
Seattle 17
Redmond 16
Montreal 15
Helsinki 14
Washington 14
Chicago 12
Haiphong 10
Stockholm 10
Tokyo 10
Turku 10
Warsaw 10
Xi'an 9
Boston 8
Milan 8
Ankara 7
Biên Hòa 7
Canberra 6
Johannesburg 6
Charlotte 5
Chennai 5
Denver 5
Hyderabad 5
Las Vegas 5
Melbourne 5
Naples 5
Paris 5
Phoenix 5
Yeonsu-gu 5
Atlanta 4
Bauru 4
Buenos Aires 4
Campinas 4
Curitiba 4
Ha Long 4
Miami 4
New Delhi 4
Ninh Bình 4
Oklahoma City 4
Padova 4
Ribeirão Preto 4
Rio de Janeiro 4
Riyadh 4
Sona 4
Vienna 4
West Jordan 4
Asunción 3
Athens 3
Camaçari 3
Capaccio 3
Copenhagen 3
Durham 3
Manchester 3
Montesilvano Marina 3
Moscow 3
Ningbo 3
Pescara 3
Porto 3
Porto Alegre 3
Quito 3
Tashkent 3
Anyang 2
Astana 2
Baku 2
Belo Horizonte 2
Boca Raton 2
Buffalo 2
Bắc Giang 2
Caluire-et-Cuire 2
Campina Grande 2
Cape Town 2
Catanduva 2
Catania 2
Charleston 2
Contagem 2
Da Nang 2
Totale 3.244
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 248
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 228
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 219
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 211
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 211
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 210
Designing a broad-spectrum integrative approach for cancer prevention and treatment 210
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 203
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 197
Premetastatic niche: ready for new therapeutic interventions? 196
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 174
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 172
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 126
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 125
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 115
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 112
Anterior and posterior vaginal myomectomy: A new surgical technique 106
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 106
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 104
Biological effects of cabozantinib on bone microenvironment 101
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 98
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 96
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 96
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 94
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 94
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 94
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 94
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 94
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 93
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 93
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 92
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 92
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 92
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 90
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 89
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 88
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 88
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 67
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma 61
Molecular prognostic factors in patients with pancreatic cancer 53
New targets, new drugs for metastatic bone pain: a new philosophy 51
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 50
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 48
MicroRNAs and bone metastasis: a new challenge 42
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 40
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 39
Denosumab for cancer-related bone loss 38
New Technologies to Study the Interplay between Cancer Stem Cells and the Immune System 37
Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis 36
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence 36
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 36
Network approach in liquidomics landscape 36
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 35
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 35
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs) 35
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 35
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 34
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 33
Epidemiologia e caratteristiche delle metastasi ossee 33
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 32
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 32
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 32
Targeting bone metastases starting from the preneoplastic niche: home sweet home 31
CETUXIMAB: From bench to bedside 31
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 30
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 30
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 30
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials. 30
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study 30
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 30
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 30
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation 30
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 29
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 29
Oncologia 29
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 29
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 28
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 28
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 28
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 28
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 28
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 28
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 28
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 27
Bone Health in Cancer Patients 27
The role of bone microenvironment, vitamin D and calcium 27
Monoclonal antibodies 27
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 27
TUMORI NEUROENDOCRINI 26
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 26
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 26
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 26
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 25
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 25
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 25
Emerging Therapeutic Targets in Osteoncology 25
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 25
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 25
Emerging drugs for the treatment of bone metastasis 25
Facing SARS-CoV-2 outbreak in immunotherapy era 25
Totale 7.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/20255.748 76 92 206 49 39 137 115 31 491 456 1.794 2.262
2025/20261.746 484 226 397 511 128 0 0 0 0 0 0 0
Totale 8.393